Study of SSS06 for anemia from chemotherapy
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a new drug, SSS06, for treating anemia caused by chemotherapy in people with certain cancers. The goal is to see if it can help raise red blood cell levels safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a cancer that is not a blood cancer like leukemia or myeloma.
- Your hemoglobin level is 100 g/L or lower, and it dropped at least 10 g/L after starting chemotherapy.
- You have enough iron stores (ferritin at least 50 ng/mL and transferrin saturation at least 10%).
- You weigh at least 40 kg (about 88 lbs).
- You are able to take care of yourself (ECOG score 1 or 2) and expected to live at least 6 more months.
- You plan to receive at least 8 more weeks of chemotherapy that can lower blood counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, AND017, to see if it can help raise hemoglobin levels in people with cancer who have anemia from chemotherapy. It's for patients with non-blood cancers who are still receiving certain types of chemo or targeted therapy.
This study tests a new medication (SAL-0951) for treating low red blood cell counts (anemia) caused by chemotherapy in people with certain types of cancer that are not curable. It may help improve energy and reduce the need for blood transfusions.
This trial tests an experimental drug, HS-20106, to see if it can improve low red blood cell counts (anemia) for people with a certain type of bone marrow disorder called myelodysplastic syndromes (MDS), which is not high risk. It might be an option if you have not received certain prior treatments.
This trial tests a new drug, SSS59, in people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and how it affects the body.
This trial tests an experimental drug called AND017 to treat anemia (low red blood cells) in people with cancer who are not currently receiving chemotherapy. The goal is to see if it can raise hemoglobin levels and improve energy.
This trial tests whether giving iron (iron sucrose) can reduce anemia during chemotherapy before curative surgery. It may help you feel better and have smoother treatment by improving low blood counts caused by iron deficiency.
Hear when a new Chemotherapy-induced Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.